We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
iShares Silver Trust
SLV
$28.1B
| $28.3M | 0.05% |
1,234,800
+795,500
| +181% | +$17.7M |
|
377
Exelixis
EXEL
$13.9B
| $28.2M | 0.05% |
1,245,947
+1,027,070
| +469% | +$20.1M |
|
378
BioMarin Pharmaceuticals
BMRN
$11.5B
| $28.2M | 0.05% |
366,180
-263,254
| -42% | -$22M |
|
|
SAIL
379
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $28.2M | 0.05% |
550,269
+476,845
| +649% | +$20.4M |
|
380
Starwood Property Trust
STWD
$6.12B
| $28.1M | 0.05% |
1,163,107
-1,323,189
| -53% | -$32M |
|
381
Duke Energy
DUK
$102B
| $28.1M | 0.05% |
251,642
-55,807
| -18% | -$5.8M |
|
382
Ultragenyx Pharmaceutical
RARE
$2.65B
| $28M | 0.05% |
385,453
+151,223
| +65% | +$10.5M |
|
383
Regal Rexnord
RRX
$14.2B
| $28M | 0.05% |
187,966
+600
| +0.3% | +$96.2K |
|
384
Intel
INTC
$466B
| $27.9M | 0.05% |
563,377
-1,797,791
| -76% | -$89.1M |
|
|
JNPR
385
DELISTED
Juniper Networks
JNPR
| $27.8M | 0.05% |
749,116
+226,724
| +43% | +$7.79M |
|
|
GOOS
386
Canada Goose Holdings
GOOS
$868M
| $27.7M | 0.05% |
1,051,123
-160,608
| -13% | -$4.61M |
|
|
387
CALL
iShares Silver Trust
SLV
$28.1B
| $27.6M | 0.05% |
1,207,100
+788,900
| +189% | +$17.5M |
|
|
CYBR
388
DELISTED
CyberArk
CYBR
| $27.5M | 0.05% |
163,102
-200,830
| -55% | -$30.5M |
|
389
MarketAxess Holdings
MKTX
$4.15B
| $27.5M | 0.05% |
80,811
+63,733
| +373% | +$23.1M |
|
|
SLAM
390
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $27.5M | 0.05% |
2,813,848
| – | – |
|
391
Boeing
BA
$165B
| $27.2M | 0.05% |
+142,001
| New | +$28.5M |
|
392
Qualcomm
QCOM
$176B
| $27.2M | 0.05% |
177,808
-537,024
| -75% | -$90.1M |
|
|
SCOA
393
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $27.1M | 0.05% |
2,762,457
| – | – |
|
394
Western Union
WU
$2.57B
| $26.9M | 0.05% |
+1,438,049
| New | +$26.6M |
|
395
Inspire Medical Systems
INSP
$1.42B
| $26.9M | 0.05% |
104,799
-250,762
| -71% | -$57.3M |
|
|
CHS
396
DELISTED
Chicos FAS, Inc.
CHS
| $26.8M | 0.05% |
5,584,519
+3,729,294
| +201% | +$17.5M |
|
|
SVFA
397
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $26.7M | 0.05% |
2,722,746
| – | – |
|
398
Ambarella
AMBA
$2.99B
| $26.4M | 0.05% |
251,476
-58,189
| -19% | -$7.42M |
|
|
LGAC
399
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $26.4M | 0.05% |
2,692,165
| – | – |
|
400
Sunrun
RUN
$2.37B
| $26.3M | 0.05% |
866,898
-116,159
| -12% | -$3.24M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.